MENU

ATOS Atossa Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of products for breast cancer

Industry Biotechnology
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ATOS is expected to report earnings to rise 8.33% to -6 cents per share on March 27

Atossa Therapeutics ATOS Stock Earnings Reports
Q4'24
Est.
$-0.06
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
Q4'23
Est.
$-0.06
The last earnings report on November 12 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 1.48M shares outstanding, the current market capitalization sits at 124.54M.
A.I. Advisor
published General Information

General Information

a manufacturer of products for breast cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ATOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-2.80%
ABOS - ATOS
41%
Loosely correlated
-0.51%
ABCL - ATOS
39%
Loosely correlated
-2.45%
GBIO - ATOS
38%
Loosely correlated
-6.03%
DNLI - ATOS
38%
Loosely correlated
-0.30%
ALLO - ATOS
38%
Loosely correlated
+0.49%
More